¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"autonomic part of peripheral nervous system"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • pride system
    ÀÚ±àü°è
  • primary signalling system
    ÀÏÂ÷½Åȣü°è
  • projective system
    Åõ»çü°è
  • real time system
    ½Ç½Ã°£Ã¼°è
  • registration system
    ½Å°íÁ¦µµ, µî·ÏÁ¦µµ
  • remote afterloading system
    ¿ø°ÝÁ¶ÀÛÈÄÀåÁø¹ý
  • reproductive system
    »ý½Ä°èÅë
  • respiratory system
    È£Èí°èÅë
  • reticuloendothelial system
    ±×¹°³»ÇǰèÅë, ¼¼¸Á³»ÇǰèÅë
  • Rh blood group system
    ¾Ë¿¡ÃëÇ÷¾×Çü±º
  • self-system
    ÀÚ±âü°è
  • system
    °èÅë, ÀåÄ¡, Á¦µµ
  • scavenging system
    ¸¶Ãë°¡½ºÁ¦°Åü°è
  • skeletal system
    »À´ë°èÅë
  • social security system
    »çȸº¸ÀåÁ¦µµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • pituitary portal system
    ³úÇϼöü¹®¸Æ°è(¡­Ú¦ØæÍ§).
  • pneumatic tube system
    ±â¼Û°üÀåÄ¡(ѨáêηíûöÇ)
  • portal system
    ¹®¸Æ°è(Ú¦ØæÍ§).
  • pride system
    ÀÚ±àü°è£¨í»Ðèô÷ͧ£©
  • primary signal system
    ÀÏÂ÷½ÅÈ£°è(ìéó­ãáûÜ Í§).
  • primary signalling system
    ÀÏÂ÷Àû¡¡½Åȣü°è
  • primitive duct system
    ¿ø½Ã°ü°èÅë
  • projective system
    Åõ»çü°è
  • real time system
    ½Ç½Ã°£ ü°è
  • reciprocal system
    »ó¹Ý°è(ßÓÚãͧ).
  • recirculating system
    Àç¼øÈ¯(¹æ)½Ä .
  • redox system
    »êȭȯ¿ø°è(ß«ûùü»êªÍ§).
  • registration system
    ½Å°íÁ¦µµ(Ëà˭̡̬).
  • remote afterloading system,RALS
    ¿ø°ÝÁ¶ÀÛÈÄÀåÁø¹ý
  • renal collecting system
    ½ÅÁýÇÕ°ü°èÅë(ãìó¢ùêηͧ÷Ö).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • peripheral neuropathy
    ¸»ÃʽŰ溴Áõ(ØÇôþãêÌèÜ»ñø)
  • peripheral neuropathy,diphtheritic
    µðÇÁÅ׸®¾Æ¼º(¡­àõ)
  • peripheral paraplegia
    ¸»ÃʽŰ漺 ´ë¸¶ºñ(¡­Óß Ýö).
  • peripheral primintive neuroectodermal tumors
  • peripheral pulse
    ¸»ÃʸƹÚ(¡­ØæÚÑ).
  • peripheral receptive field
    ¸»Ãʼö¿ë¾ß(¡­áôé»å¯).
  • peripheral resistance
    ¸»ÃÊÀúÇ×(¡­î½ù÷).
  • peripheral resistance unit
    ¸»ÃÊÀúÇ×´ÜÀ§(¡­Ó¤êÈ).
  • peripheral retina
    ÁÖº¯¸Á¸·
  • peripheral retinitis
    ÁÖº¯¸Á¸·¿°
  • peripheral rim enhancement
    Å׵θ® Á¶¿µÁõ°­
  • peripheral scatter photocoagulation
    ÁÖº¯ºÎ»ê¶õ±¤ÀÀ°í
  • peripheral scotoma
    ÁÖº¯¾ÏÁ¡(ñ²Ü«äÞïÇ).
  • peripheral sensitization
    ¸»Ãʰ¨ÀÛ.
  • peripheral smear
    ¸»ÃÊÇ÷¾×µµ¸»(ØÇôþúìäûÓóØÆ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • Supraclavicular part
    ºøÀåÀ§ºÎºÐ
    [¿¾ ¿ë¾î] ¼â°ñ»óºÎ
  • Bony part
    »ÀºÎºÐ
    [¿¾ ¿ë¾î] °ñºÎºÐ
  • Osseous part
    »ÀºÎºÐ
    [¿¾ ¿ë¾î] °ñºÎ
  • Osseous part
    »ÀºÎºÐ
    [¿¾ ¿ë¾î] À̰ü°ñºÎ
  • Glandular part
    »ùºÎºÐ
    [¿¾ ¿ë¾î] ¼±ºÎ
  • Annular part of digital fibrous sheath
    ¼¶À¯Áý°í¸®ºÎºÐ
    [¿¾ ¿ë¾î] ¼¶À¯ÃÊÀ±»óºÎ
  • Annular part of digital fibrous sheath
    ¼¶À¯Áý°í¸®ºÎºÐ
    [¿¾ ¿ë¾î] Á·Áö¼¶À¯ÃÊÀ±»óºÎ
  • Cruciate part of digital fibrous sheath
    ¼¶À¯Áý½ÊÀںκÐ
    [¿¾ ¿ë¾î] ¼¶À¯ÃʽÊÀÚºÎ
  • Cruciate part of digital fibrous sheath
    ¼¶À¯Áý½ÊÀںκÐ
    [¿¾ ¿ë¾î] Á·Áö¼¶À¯ÃʽÊÀÚºÎ
  • Triangular part
    ¼¼¸ðºÎºÐ
    [¿¾ ¿ë¾î] »ï°¢ºÎ
  • Extracellular part
    ¼¼Æ÷¹Ù±ùºÎºÐ
    [¿¾ ¿ë¾î] ¼¼Æ÷¿ÜºÎ
  • Intracellular part
    ¼¼Æ÷¼ÓºÎºÐ
    [¿¾ ¿ë¾î] ¼¼Æ÷³»ºÎ
  • Third ventricle (part)
    ¼Â°³ú½Ç(ºÎºÐ)
    [¿¾ ¿ë¾î] Á¦3³ú½Ç
  • Internal part
    ¼ÓºÎºÐ
    [¿¾ ¿ë¾î] ³»ÃøºÎ
  • Thalamolenticular part
    ½Ã»ó·»ÁîÇٺκÐ
    [¿¾ ¿ë¾î] ½Ã»ó·»ÁîÇÙºÎ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
MCS malignant carcinoid syndrome; managed care system; massage of the carotid sinus; mesocaval shunt; me...
MHS major histocompatibility system; malignant hyperthermia in swine; malignant hyperthermia syndrome; m...
MIMS medical information management system; medical inventory management system
PDS pain-dysfunction syndrome; paroxysmal depolarizing shift; patient data system; Patient-Doctor Societ...
PPS Personal Preference Scale; physician, patient and society [course]; polyvalent pneumococcal polysacc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
PVD Peripheral Vascular Disease
PAS Peripheral anterior synechiae
PAD Peripheral arterial disease
PAOD Peripheral arterial occlusive disease
PBzR Peripheral benzodiazepine receptor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • condensed system
    ÀÀ»ó°è
  • conduction system
    ÈïºÐ Àüµµ°è
  • control system
    Á¶Àý°è
  • corticospinal system
    ÇÇÁú ô¼ö°è
  • countercurrent system
    ¿ª·ù°è, ´ëÇâ·ù°è
  • crystal system
    Á¤°è, °áÁ¤°è
  • cyclic AMP system
    ȯ»ó AMP °è
  • descending inhibitory system
    ÇÏÇà ¾ïÁ¦°è
  • digestive system
    ¼ÒÈ­±â °èÅë
  • disease of the lymphreticular system
    ¸²ÇÁ ¼¼¸Á³»ÇǰèÀÇ Áúȯ
  • DNA repair system
    DNA º¸¼ö ±â±¸
  • dopaminergic system
    µµÆÄ¹Î ü°è
  • drug delivery system
    ¾à¹° Åõ¿©±â, ¾à¹° Åõ¿© üÁ¦, ¾à¹° Àü´Þ ü°è
  • dual foil system
    ÀÌÁß ¹Ú¸· ±¸Á¶
  • ductal system
    µµ°ü°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
phosphoenolpyruvate sugar phosphotransferase system <enzyme> The bacterial sugar phosphotransferase system (pts) that catalyses the transfer of the phosphoryl group from phosphoenolpyruvate to its sugar substrates (the pts sugars) concomitant with the translocation of these sugars across the bacterial membrane. The phosphorylation of a given sugar requires four proteins, two general proteins, enzyme I and hpr and a pair of sugar-specific proteins designated as the enzyme II complex. The pts has also been implicated in the induction of synthesis of some catabolic enzyme systems required for the utilization of sugars that are not substrates of the pts as well as the regulation of the activity of adenylate cyclase.
Registry number: EC 2.7.1.-
(12 Dec 1998)
closed system <biology, ecology> A chemical or biological system that exchanges no matter or energy with the ouside environment.
(12 Mar 1998)
mnss blood-group system A system of universal human blood group isoantigens with many associated subgroups. The m and n traits are codominant and the s and s traits are probably very closely linked alleles, including the u antigen. This system is most frequently used in paternity studies.
(12 Dec 1998)
Pinel's system The abolition of forcible restraint in the treatment of the mental hospital patient.
(05 Mar 2000)
mononuclear phagocyte system A widely distributed collection of both free and fixed macrophages derived from bone marrow precursor cells by way of monocytes; their substantial phagocytic activity is mediated by immunoglobulin and the serum complement system. In both connective and lymphoid tissue, they may occur as free and fixed macrophages; in the sinusoids of the liver, as Kupffer cells; in the lung, as alveolar macrophages; and in the nervous system, as microglia.
Synonym: system of macrophages.
(05 Mar 2000)
colloid system A combination of the two phases, internal and external, of a colloid solution; the various system's are: gas + liquid (foam); gas + solid (meerschaum); liquid + gas (fog); solid + gas (smoke); solid + liquid (sol); liquid + solid (gel); liquid + liquid (emulsion); solid + solid (coloured glass).
(05 Mar 2000)
pituitary-adrenal system The interactions between the anterior pituitary and adrenal glands, in which corticotropin (acth) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary.
(12 Dec 1998)
combined system disease A subacute or chronic disorder of the spinal cord, such as that occurring in certain patients with vitamin B12 deficiency, characterised by a slight to moderate degree of gliosis in association with spongiform degeneration of the posterior and lateral columns.
Synonym: combined sclerosis, combined system disease, funicular myelitis, Putnam-Dana syndrome, vitamin B12 neuropathy.
(05 Mar 2000)
motor system disease <disease> Degenerative disease of unknown cause that affects predominantly motor neurons of spinal cord, cranial nerve nuclei and motor cortex. There is speculation that deficiency in ciliary neurotrophic factor may be involved.
(18 Nov 1997)
complement system A group of more than 20 serum proteins, some of which can be serially activated and participate in a cascade resulting in cell lysis.
(05 Mar 2000)
conducting system of heart The system of atypical cardiac muscle fibres comprising the sinoatrial node, internodal tracts, atrioventricular node and bundle, the bundle branches, and their terminal ramifications into the Purkinje network; sometimes also called cardionector.
(05 Mar 2000)
multienzyme system A group of related enzymes that operate in a particular metabolic pathway.
(09 Oct 1997)
multiple system atrophy A name grouping together the four cerebral degenerative diseases of olivopontocerebellar atrophy, shy-drager syndrome, striatonigral degeneration, and one form of parkinson disease, considering them different forms of the same disease process.
(12 Dec 1998)
muscular system All the muscles of the body collectively.
(05 Mar 2000)
musculoskeletal system All the muscles, bones, and cartilages of the body collectively.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á